FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particularl to ophthalmology, and can be intended for treatment of retinal vein thromboses. Simultaneously 0.1 ml of kenalog and 0.1 ml of gemaza 500U are introduced intravitreally by injection through flat part of ciliary body in 4 +/-1 mm from limb.
EFFECT: method allows in maximally short period to reduce ischemic retinal edema and squeezing of its morphological structures, as well as accelerate retinal hemorrhages resorption, improve rheology of retinal channel blood with following restoration of retina receptors functions, which results in essential increase of visual acuity, application of two medications of kenalog ad gemaza simultaneously is pathogenically conditioned, because together they potentiate treatment result.
2ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR THROMBOSIS TREATMENT IN CENTRAL VEIN OF RETINA AND ITS BRANCHES | 2007 |
|
RU2337656C1 |
| METHOD FOR SURGICAL MANAGEMENT OF THROMBOSIS OF CENTRAL RETINAL VEIN AND ITS BRANCHES | 2014 |
|
RU2559939C1 |
| METHOD OF TREATMENT OF CLOTTAGE OF CENTRAL VIENNA OF RETINA | 2007 |
|
RU2352304C1 |
| METHOD OF TREATING MACULAR OEDEMA ACCOMPANYING RETINOVASCULITIS | 2013 |
|
RU2562022C2 |
| METHOD OF TREATING RETINAL AND VITREOUS HEMORRHAGE | 2013 |
|
RU2513473C1 |
| PHARMACEUTICAL COMPOSITION ELICITING THROMBOLYTIC AND FIBRINOLYTIC EFFECT | 2002 |
|
RU2216348C1 |
| METHOD FOR SURGICAL TREATMENT OF THROMBOSIS OF CENTRAL RETINAL VEIN | 2006 |
|
RU2308918C1 |
| METHOD OF TREATING OCCLUSION OF CENTRAL VEIN OF RETINA AND ITS BRANCHES | 2015 |
|
RU2603318C1 |
| METHOD OF TREATING MASSIVE SUBMACULAR HAEMORRHAGES ACCOMPANYING AGE-RELATED MACULAR DEGENERATION | 2019 |
|
RU2696056C1 |
| METHOD FOR TREATING THE CASES OF CENTRAL VEIN THROMBOSES OF RETINA | 2006 |
|
RU2305521C1 |
